AAV8-mediated Sirt1 gene transfer to the liver prevents high carbohydrate diet-induced nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is the most common hepatic disease worldwide, and evidence suggests that it promotes insulin resistance and type 2 diabetes. Caloric restriction (CR) is the only available strategy for NAFLD treatment. The protein deacetylase Sirtuin1 (SIRT1), which is activa...
Main Authors: | Laia Vilà, Ivet Elias, Carles Roca, Albert Ribera, Tura Ferré, Alba Casellas, Ricardo Lage, Sylvie Franckhauser, Fatima Bosch |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-01-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050116301061 |
Similar Items
-
AAV-mediated Sirt1 overexpression in skeletal muscle activates oxidative capacity but does not prevent insulin resistance
by: Laia Vil, et al.
Published: (2016-01-01) -
AAV-mediated BMP7 gene therapy counteracts insulin resistance and obesity
by: Estefania Casana, et al.
Published: (2022-06-01) -
Dietary carbohydrates and fats in nonalcoholic fatty liver disease
by: Yki-Järvinen, H, et al.
Published: (2021) -
Role of acetylation in nonalcoholic fatty liver disease: a focus on SIRT1 and SIRT3
by: Fatiha Nassir
Published: (2020-08-01) -
Biological Role and Related Natural Products of SIRT1 in Nonalcoholic Fatty Liver
by: Meng D, et al.
Published: (2023-12-01)